Investment Thesis
Guardant Health exhibits severe financial distress with negative stockholders' equity of -181.1M, indicating the company's liabilities exceed assets. Operating performance is critically impaired with -40.2% operating margin, flat YoY revenue growth, and negative free cash flow of -71.2M despite holding 989.3M in cash, signaling unsustainable unit economics. Without demonstrable path to profitability and positive cash generation, the company faces high financial risk despite current liquidity reserves.
Strengths
- Substantial cash reserves of 989.3M provide near-term runway
- Strong current ratio of 4.68x and quick ratio of 4.39x ensure short-term liquidity needs are met
- Significant insider activity with 40 Form 4 filings in 90 days suggests management engagement
Risks
- Negative stockholders equity of -181.1M indicates company liabilities exceed assets by this amount
- Operating cash flow is deeply negative at -65.6M; company cannot fund operations from business
- Revenue flatlined YoY with no growth momentum; coupled with losses, questions fundamental business viability
- Long-term debt of 1.5B cannot be serviced from operations with negative interest coverage of -90.1x
- Free cash flow burn of -71.2M annually will deplete cash reserves in 13+ years if unchanged
Key Metrics to Watch
- Path to operating profitability and positive operating cash flow
- Revenue growth acceleration and operating margin expansion
- Stockholders equity restoration to positive territory
- Debt reduction plan and interest coverage improvement
Financial Metrics
Revenue
301.7M
Net Income
-112.1M
EPS (Diluted)
$-0.85
Free Cash Flow
-71.2M
Total Assets
1.9B
Cash
989.3M
Profitability Ratios
Gross Margin
N/A
Operating Margin
-40.2%
Net Margin
-37.2%
ROE
N/A
ROA
-5.9%
FCF Margin
-23.6%
Balance Sheet & Liquidity
Current Ratio
4.68x
Quick Ratio
4.39x
Debt/Equity
N/A
Debt/Assets
109.5%
Interest Coverage
-90.09x
Long-term Debt
1.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T07:22:34.205755 |
Data as of: 2026-03-31 |
Powered by Claude AI